WuXi PharmaTech Schedules Fourth Quarter 2008 Earnings Release on Thursday, March 26, 2009
WUXI APPTEC LOGO. (PRNewsFoto/WUXI APPTEC LOGO)
SHANGHAI CHINA
Earnings Conference Call to be Held on March 26, 2008 at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong)
SHANGHAI, China, March 12 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman)
Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device
R&D outsourcing company with operations in China and the United States, today
announced that it will release financial results for the fourth quarter 2008
on March 26, 2008Shanghai time, and after the US market close on Wednesday,
March 25, 2008New York time.
The earnings release will be available on the investor relations section
of its website at http://www.wuxiapptec.com .
Following the earnings announcement, WuXi PharmaTech senior management
will host a conference call at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm
(Beijing/Shanghai/Hong Kong) on Thursday, March 26, 2009, to discuss its 2008
fourth quarter financial results and recent business activities. The
conference call may be accessed by calling:
United States: 1-866-519-4004
China (Landline): 800-819-0121
China (Mobile): 400-620-8038
Hong Kong: 800-933-053
United Kingdom: 0-808-234-6646
International: +65-6735-7955
Conference ID: 90240602
A telephone replay will be available two hours after the call's completion
at:
United States: 1-866-214-5335
China North: 10-800-714-0386
China South: 10-800-140-0386
Hong Kong: 800-901-596
United Kingdom: 0-800-731-7846
International: +61-2-8235-5000
Passcode: 90240602
A live webcast of the conference call and replay will be available in the
investor relations section of WuXi PharmaTech's website at
http://www.wuxiapptec.com .
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical
device R&D outsourcing company, with operations in China and the United States.
As a research-driven and customer-focused company, WuXi PharmaTech provides
pharmaceutical, biotechnology and medical device companies with a broad and
integrated portfolio of laboratory and manufacturing services throughout the
drug and medical device R&D process. WuXi PharmaTech's services are designed
to help its global partners in shortening the cycle and lowering the cost of
drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are
known as WuXi AppTec. For more information, please visit:
http://www.wuxiapptec.com .
For further information, please contact:
WuXi PharmaTech (Cayman) Inc.
Ronald Aldridge (for investors)
Director of Investor Relations
Tel: +1-215-218-5515
Email: ir@wuxiapptec.com
Sherry Shao (for the media)
WuXi PharmaTech (Cayman) Inc.
Tel: +86-21-5046-4002
Email: pr@wuxiapptec.com
